Wegovy is a prescription medication designed to aid weight loss by regulating appetite and calorie intake. When combined with a healthy diet and regular exercise, it can lead to significant weight reduction, helping you achieve your weight loss goals.

What is Wegovy?

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a hormone involved in appetite regulation. It works by influencing areas of the brain that control hunger, helping you feel fuller and reducing your calorie intake. Wegovy is administered once weekly via a subcutaneous injection using a pre-filled pen.

Who Can Use Wegovy for Weight Loss?

Wegovy is generally recommended for adults with a Body Mass Index (BMI) of 30 or higher (obesity), or those with a BMI of 27 or higher (overweight) who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. Our healthcare professionals will assess your individual needs and medical history to determine if Wegovy is suitable for you.

Is Wegovy Approved for Weight Loss in the UK?

Yes, Wegovy has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for weight loss in the UK. It is available through specialist weight management services and should be used under the guidance of a qualified healthcare provider.

How Effective is Wegovy for Weight Loss?

Clinical studies have shown that Wegovy, when used alongside a reduced-calorie diet and increased physical activity, can lead to significant weight loss. Participants in trials experienced an average weight reduction of approximately 15% of their body weight over a 15-month period.

What Are the Potential Side Effects of Wegovy?

Common side effects of Wegovy may include nausea, diarrhea, vomiting, constipation, and abdominal pain. These symptoms are generally mild to moderate and tend to decrease over time as your body adjusts to the medication. It's important to discuss any side effects with your healthcare provider.

How is Wegovy Administered?

Wegovy is administered once weekly at any time of the day, with or without meals. It is injected subcutaneously in the abdomen, thigh, or upper arm. The injection site can be changed without dose adjustment.

For more detailed information, please refer to the Patient Information Leaflet provided with your medication.

Note: This information is intended for educational purposes and should not replace professional medical advice. Always consult with a healthcare provider for personalized guidance and treatment options.